Clinical Trial Update: Evaluation of the Efficacy and Safety of [18F]-ML-10, as a PET Imaging Radiotracer, in Early Detection of Response of Brain Metastases of Solid Tumors to Radiation Therapy. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the PET imaging tracer [18F]-ML-10 for early detection of response of brain metastases from solid tumors to radiation t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Solid Tumors

Drugs mentioned

• [18F]-ML-10 (Fluorine-18 ML-10)

Snippet

Sponsor: Aposense Ltd. | Conditions: Brain Metastases, Solid Tumors | Phase 2 | Status: UNKNOWN